People have tested a liposomal nanoparticle loaded with synthetic miRNA-34a mimics (MRX34) that against cancer cells when combined with the EGFR-TKI Erlotinib treatment (Bader, 2012; Zhao et al., 2014). The gene discussed is EGFR; the disease is cancer.